Proxy Statement

Amphastar Pharmaceuticals, Inc. Filed 2016-04-22 Acc 0001297184-16-000003

Documents 1

2017-04-21 DEF 14A Proxy Statement
2016-04-22 DEFA14A Proxy Materials
2016-04-22 DEF 14A Proxy Statement
2016-04-22 4 CFO, SVP & Treasurer gave up 1,383 shares (to pay taxes)
2016-04-20 4 EVP, QA & Regulatory Affairs sold 21,244 shares at an average $12.89 ($273,774)
2016-04-18 4 EVP, QA & Regulatory Affairs gave up 741 shares (to pay taxes)
2015-04-08 DEF 14A Proxy Statement

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading amph-20160609xdef14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…